A Label-Free Segmentation Approach for Intravital Imaging of Mammary Tumor Microenvironment
May 24th, 2022
The intravital imaging method described here utilizes collagen second harmonic generation and endogenous fluorescence from the metabolic co-factor NAD(P)H to non-invasively segment an unlabeled tumor microenvironment into tumor, stromal, and vascular compartments for in-depth analysis of 4D intravital images.
View the full transcript and gain access to thousands of scientific videos
Overview
This article describes an intravital imaging method that utilizes collagen second harmonic generation and endogenous fluorescence from NAD(P)H. The technique allows for non-invasive segmentation of the tumor microenvironment into distinct compartments for detailed analysis.
Key Study Components
Area of Science
- Neuroscience
- Biology
- Imaging Techniques
Background
- Intravital imaging enables observation of physiological interactions within the tumor microenvironment.
- The method minimizes manipulations to the subject by using label-free signals.
- Understanding dynamic interactions relative to extracellular matrix and vascular structures is crucial.
- This approach is broadly applicable across various intravital systems.
Purpose of Study
- To observe and analyze dynamic behaviors in the tumor microenvironment.
- To segment the tumor microenvironment into tumor, stromal, and vascular compartments.
- To demonstrate a minimally invasive imaging technique.
Methods Used
- Collagen second harmonic generation imaging.
- Endogenous fluorescence from NAD(P)H.
- Preparation of a mammary imaging window cover glass.
- Use of cyanoacrylate adhesive for securing the cover glass.
Main Results
- Successful segmentation of the tumor microenvironment.
- Demonstration of the imaging technique by researchers.
- Minimized manipulation of the mouse during imaging.
- Broad applicability of the method to various research contexts.
Conclusions
- The method provides a non-invasive way to study tumor dynamics.
- It enhances understanding of interactions within the tumor microenvironment.
- This imaging technique can be adapted for various intravital studies.
Frequently Asked Questions
Executive Industry Relevance
Label-free intravital imaging and segmentation of the tumor microenvironment enables high-fidelity, non-invasive analysis of dynamic cell-ECM and vascular interactions in live tumor models. This approach enhances predictive confidence in preclinical oncology research by providing spatial and metabolic context without exogenous labels, supporting translational continuity for patient-derived xenograft (PDX) studies. The workflow addresses a critical inflection point in early discovery and preclinical validation by enabling robust compartmentalization of tumor, stroma, and vasculature domains.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables functional mapping of tumor-stroma-vasculature interactions in live models.
- Supports biological de-risking by revealing spatial and metabolic heterogeneity.
- Facilitates mechanistic interrogation of tumor progression pathways.
- Improves predictive confidence for target validation in complex tissue contexts.
Screening & Assay Development
- Provides validated, label-free segmentation for downstream quantitative imaging assays.
- Standardizes compartment identification for reproducible phenotypic screening.
- Enables assay scalability and platform reuse across diverse tumor models.
- Supports reliable evaluation of compound effects on distinct tumor microenvironment domains.
Translational & Preclinical Research
- Aligns with disease-relevant systems by supporting PDX and human tissue models.
- Maintains translational continuity by avoiding exogenous labels incompatible with clinical samples.
- Enables risk-adjusted advancement decisions based on spatially resolved metabolic signatures.
- Provides mechanistic de-risking for preclinical candidate selection.
Pipeline & Workflow Integration
This label-free imaging and segmentation workflow integrates from early discovery through preclinical validation, supporting lead identification and translational research in oncology.
- Discovery Biology: Enables hypothesis testing of cell-ECM and vascular interactions in situ.
- Screening: Delivers reproducible, quantitative compartmentalization for assay development.
- Analytics: Provides spatially and metabolically resolved readouts for comparative analysis.
- Translational Research: Supports biomarker alignment and continuity from animal models to clinical samples.
- Enterprise Reuse: Establishes a reusable imaging and segmentation capability for diverse tumor models.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in tumor biology.
- Operational Value: Standardizes imaging and segmentation for reproducibility and scalability.
- Strategic Value: Enables better go/no-go decisions and reduces late-stage biological risk.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of oncology assets.
Implementation Considerations
- Requires expertise in intravital imaging and fluorescence lifetime microscopy.
- Needs advanced microscopy platforms with SHG and FLIM capabilities.
- Demands cross-team standardization of imaging and segmentation protocols.
- Adaptable to various tumor models, including PDX and human tissues.
- Imaging stability and animal handling are critical for high-quality data acquisition.
Biopharma FAQs
Chapters in this video
0:04
introduction
0:55
Generation and Surgical Implantation of the Mammary Imaging Window (MIW)
4:13
Positioning and Maintaining Mouse on the Microscope Stage for Imaging
5:52
Set Up for 4D, Intensity-Based, Label-Free Intravital Imaging of Dynamic Cell Behavior
8:02
Fluorescence Lifetime Imaging (FLIM) of NAD(P)H
8:43
Results: Intravital Imaging of the Mammary Tumor Microenvironment
10:15
Conclusion
